Company intelligence / Profile preview

Goodier

Dallas, Texas, United Statesgoodier.com ↗

Ownership: Private
Employees: ~95
Development stage: Commercial

Overview

Goodier develops and manufactures a wide range of clinically proven OTC and medical-grade skincare products for global brands. The company has a century-long track record in innovation-driven contract manufacturing with regulatory compliance for FDA/cGMP/OTC/510(k) products. It does not have its own clinical pipeline but supports client brands from formulation through commercialization.

Therapeutic areas: Dermatology
Modalities: Small moleculeBiologicDevice
Industry: Contract Manufacturing Organization

Partnerships

Mary Kay®Revision Skincare

Beyond the preview

Go deeper on Goodier.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Goodier.

Explore the full profile